The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
October 23rd 2024
In the complete response letter, the FDA classified deficiencies in the Abbreviated New Drug Application for ketamine as MINOR.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Stress in the Workplace may Decrease an Individual's Risk for Developing Rheumatoid Arthritis
September 10th 2009Psychosocial work stress has been previously associated with an increased risk for cardiovascular disease. New research now reveals that high work stress may actually decrease an individual's chance of developing inflammatory conditions, including rheumatoid arthritis.
Majority of Chronic Pain Patients Improperly Use Prescribed Medications
August 27th 2009An Ameritox study found that of 938,586 urine toxicology tests administered to chronic pain patients over a three-year period, 11% detected major illicit drugs and 29% had a medication in their system that the patient's doctor was likely unaware of.
FDA now Requires Stronger Warning Labels for Tumor-necrosis Factor-alpha Blockers
August 21st 2009The FDA is now requiring that stronger product warnings be included in the prescribing information of tumor necrosis factor-alpha blockers because of an increased risk of cancer in the children and adolescents who take them.
New Inhaled Therapy Provides Significant Relief from Migraine Pain
August 20th 2009Researchers from the Jefferson Headache Center have completed a multi-center, phase 3 clinical trial demonstrating that Levadex, an orally-inhaled migraine therapy, provides “significant relief” from migraine symptoms.
The Latest News on the Obama Administration's Plans for Healthcare Reform
May 15th 2009Pundits, analysts, and other industry observers have been weighing in with their thoughts on what the President's proposals will call for, what effect they may have on the nation's healthcare system, their chances of being enacted, and how we're going to pay for it all.